Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolving treatment paradigms for PCV.
Fenner BJ, Cheung CMG, Sim SS, Lee WK, Staurenghi G, Lai TYY, Ruamviboonsuk P, Kokame G, Yanagi Y, Teo KYC. Fenner BJ, et al. Among authors: ruamviboonsuk p. Eye (Lond). 2022 Feb;36(2):257-265. doi: 10.1038/s41433-021-01688-7. Epub 2021 Jul 14. Eye (Lond). 2022. PMID: 34262165 Free PMC article. Review.
Cost-Utility Analysis of Deep Learning and Trained Human Graders for Diabetic Retinopathy Screening in a Nationwide Program.
Srisubat A, Kittrongsiri K, Sangroongruangsri S, Khemvaranan C, Shreibati JB, Ching J, Hernandez J, Tiwari R, Hersch F, Liu Y, Hanutsaha P, Ruamviboonsuk V, Turongkaravee S, Raman R, Ruamviboonsuk P. Srisubat A, et al. Among authors: ruamviboonsuk p, ruamviboonsuk v. Ophthalmol Ther. 2023 Apr;12(2):1339-1357. doi: 10.1007/s40123-023-00688-y. Epub 2023 Feb 25. Ophthalmol Ther. 2023. PMID: 36841895 Free PMC article.
Investigating public behavior with artificial intelligence-assisted detection of face mask wearing during the COVID-19 pandemic.
Seresirikachorn K, Ruamviboonsuk P, Soonthornworasiri N, Singhanetr P, Prakayaphun T, Kaothanthong N, Somwangthanaroj S, Theeramunkong T. Seresirikachorn K, et al. Among authors: ruamviboonsuk p. PLoS One. 2023 Apr 11;18(4):e0281841. doi: 10.1371/journal.pone.0281841. eCollection 2023. PLoS One. 2023. PMID: 37040359 Free PMC article.
EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.
Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH. Koh A, et al. Among authors: ruamviboonsuk p. Retina. 2012 Sep;32(8):1453-64. doi: 10.1097/IAE.0b013e31824f91e8. Retina. 2012. PMID: 22426346 Clinical Trial.
Anti-VEGF Therapy for Neovascular AMD and Polypoidal Choroidal Vasculopathy.
Cheung GCM, Lai TYY, Gomi F, Ruamviboonsuk P, Koh A, Lee WK. Cheung GCM, et al. Among authors: ruamviboonsuk p. Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):527-534. doi: 10.22608/APO.2017260. Epub 2017 Oct 3. Asia Pac J Ophthalmol (Phila). 2017. PMID: 28971633 Free article. Review.
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.
Koh A, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH, Lee WK; EVEREST II study group. Koh A, et al. Among authors: ruamviboonsuk p. JAMA Ophthalmol. 2017 Nov 1;135(11):1206-1213. doi: 10.1001/jamaophthalmol.2017.4030. JAMA Ophthalmol. 2017. PMID: 28983556 Free PMC article. Clinical Trial.
90 results